1 1458 90 INFLUENCE OF YOGA ON BLOOD COAGULATION. YOGA IS KNOWN TO INDUCE BENEFICIAL EFFECTS ON PHYSIOLOGICAL, BIOCHEMICAL AND MENTAL FUNCTIONS IN MAN. ITS EFFECTS ON BLOOD COAGULATION ARE NOT KNOWN. A STUDY WAS CONDUCTED IN SEVEN PREVIOUSLY UNTRAINED MALE ADULTS WHO UNDERWENT A COMBINATION OF YOGIC EXERCISES, DAILY FOR ONE HOUR, OVER A PERIOD OF FOUR MONTHS. PARAMETERS OF BLOOD COAGULATION WERE ESTIMATED BEFORE AND AFTER THE END OF YOGA TRAINING. THE FOLLOWING CHANGES WERE OBSERVED: FIBRINOLYTIC ACTIVITY INCREASED SIGNIFICANTLY WITH A CONCOMITANT FALL IN FIBRINOGEN; ACTIVATED PARTIAL THROMBOPLASTIN TIME AND PLATELET AGGREGATION TIME WERE PROLONGED; BLOOD AND PLASMA PLATELETS SHOWED A RISE; AND BOTH HAEMOGLOBIN AND HEAMATOCRIT WERE RAISED AT THE END OF THE TRAINING. THESE FINDINGS SUGGEST THAT YOGA INDUCES A STATE OF BLOOD HYPOCOAGULABILITY. THE IMPACT OF YOGA ON PREVENTION OF CARDIOVASCULAR AND THROMBOTIC DISORDERS IS OBVIOUS. 1984 2 2245 32 THE INFLUENCE OF YOGA-BASED PROGRAMS ON RISK PROFILES IN ADULTS WITH TYPE 2 DIABETES MELLITUS: A SYSTEMATIC REVIEW. THERE IS GROWING EVIDENCE THAT YOGA MAY OFFER A SAFE AND COST-EFFECTIVE INTERVENTION FOR TYPE 2 DIABETES MELLITUS (DM 2). HOWEVER, SYSTEMATIC REVIEWS ARE LACKING. THIS ARTICLE CRITICALLY REVIEWS THE PUBLISHED LITERATURE REGARDING THE EFFECTS OF YOGA-BASED PROGRAMS ON PHYSIOLOGIC AND ANTHROPOMETRIC RISK PROFILES AND RELATED CLINICAL OUTCOMES IN ADULTS WITH DM 2. WE PERFORMED A COMPREHENSIVE LITERATURE SEARCH USING FOUR COMPUTERIZED ENGLISH AND INDIAN SCIENTIFIC DATABASES. THE SEARCH WAS RESTRICTED TO ORIGINAL STUDIES (1970-2006) THAT EVALUATED THE METABOLIC AND CLINICAL EFFECTS OF YOGA IN ADULTS WITH DM 2. STUDIES TARGETING CLINICAL POPULATIONS WITH CARDIOVASCULAR DISORDERS THAT INCLUDED ADULTS WITH COMORBID DM WERE ALSO EVALUATED. DATA WERE EXTRACTED REGARDING STUDY DESIGN, SETTING, TARGET POPULATION, INTERVENTION, COMPARISON GROUP OR CONDITION, OUTCOME ASSESSMENT, DATA ANALYSIS AND PRESENTATION, FOLLOW-UP, AND KEY RESULTS, AND THE QUALITY OF EACH STUDY WAS EVALUATED ACCORDING TO SPECIFIC PREDETERMINED CRITERIA. WE IDENTIFIED 25 ELIGIBLE STUDIES, INCLUDING 15 UNCONTROLLED TRIALS, 6 NON-RANDOMIZED CONTROLLED TRIALS AND 4 RANDOMIZED CONTROLLED TRIALS (RCTS). OVERALL, THESE STUDIES SUGGEST BENEFICIAL CHANGES IN SEVERAL RISK INDICES, INCLUDING GLUCOSE TOLERANCE AND INSULIN SENSITIVITY, LIPID PROFILES, ANTHROPOMETRIC CHARACTERISTICS, BLOOD PRESSURE, OXIDATIVE STRESS, COAGULATION PROFILES, SYMPATHETIC ACTIVATION AND PULMONARY FUNCTION, AS WELL AS IMPROVEMENT IN SPECIFIC CLINICAL OUTCOMES. YOGA MAY IMPROVE RISK PROFILES IN ADULTS WITH DM 2, AND MAY HAVE PROMISE FOR THE PREVENTION AND MANAGEMENT OF CARDIOVASCULAR COMPLICATIONS IN THIS POPULATION. HOWEVER, THE LIMITATIONS CHARACTERIZING MOST STUDIES PRECLUDE DRAWING FIRM CONCLUSIONS. ADDITIONAL HIGH-QUALITY RCTS ARE NEEDED TO CONFIRM AND FURTHER ELUCIDATE THE EFFECTS OF STANDARDIZED YOGA PROGRAMS IN POPULATIONS WITH DM 2. 2007 3 1136 26 EFFICACY OF YOGA ON PREGNANCY OUTCOME. OBJECTIVE: TO STUDY THE EFFICACY OF YOGA ON PREGNANCY OUTCOMES. DESIGN AND SETTING: THREE HUNDRED THIRTY FIVE (335) WOMEN ATTENDING THE ANTENATAL CLINIC AT GUNASHEELA SURGICAL AND MATERNITY HOSPITAL IN BANGALORE, INDIA, WERE ENROLLED BETWEEN 18 AND 20 WEEKS OF PREGNANCY IN A PROSPECTIVE, MATCHED, OBSERVATIONAL STUDY; 169 WOMEN IN THE YOGA GROUP AND 166 WOMEN IN THE CONTROL GROUP. METHODS: WOMEN WERE MATCHED FOR AGE, PARITY, BODY WEIGHT, AND DOPPLER VELOCIMETRY SCORES OF UMBILICAL AND UTERINE ARTERIES. YOGA PRACTICES, INCLUDING PHYSICAL POSTURES, BREATHING, AND MEDITATION WERE PRACTICED BY THE YOGA GROUP ONE HOUR DAILY, FROM THE DATE OF ENTRY INTO THE STUDY UNTIL DELIVERY. THE CONTROL GROUP WALKED 30 MINUTES TWICE A DAY (STANDARD OBSTETRIC ADVICE) DURING THE STUDY PERIOD. COMPLIANCE IN BOTH GROUPS WAS ENSURED BY FREQUENT TELEPHONE CALLS AND STRICT MAINTENANCE OF AN ACTIVITY DIARY. MAIN OUTCOMES: BIRTH WEIGHT AND GESTATIONAL AGE AT DELIVERY WERE PRIMARY OUTCOMES. RESULTS: THE NUMBER OF BABIES WITH BIRTH WEIGHT > OR = 2500 GRAMS WAS SIGNIFICANTLY HIGHER (P < 0.01) IN THE YOGA GROUP. PRETERM LABOR WAS SIGNIFICANTLY LOWER (P < 0.0006) IN THE YOGA GROUP. COMPLICATIONS SUCH AS ISOLATED INTRAUTERINE GROWTH RETARDATION (IUGR) (P < 0.003) AND PREGNANCY-INDUCED HYPERTENSION (PIH) WITH ASSOCIATED IUGR (P < 0.025) WERE ALSO SIGNIFICANTLY LOWER IN THE YOGA GROUP. THERE WERE NO SIGNIFICANT ADVERSE EFFECTS NOTED IN THE YOGA GROUP. CONCLUSIONS: AN INTEGRATED APPROACH TO YOGA DURING PREGNANCY IS SAFE. IT IMPROVES BIRTH WEIGHT, DECREASES PRETERM LABOR, AND DECREASES IUGR EITHER IN ISOLATION OR ASSOCIATED WITH PIH, WITH NO INCREASED COMPLICATIONS. 2005 4 1910 27 RISK INDICES ASSOCIATED WITH THE INSULIN RESISTANCE SYNDROME, CARDIOVASCULAR DISEASE, AND POSSIBLE PROTECTION WITH YOGA: A SYSTEMATIC REVIEW. OBJECTIVE: TO CONDUCT A SYSTEMATIC REVIEW OF PUBLISHED LITERATURE REGARDING THE EFFECTS OF YOGA, A PROMISING MIND-BODY THERAPY, ON SPECIFIC ANTHROPOMETRIC AND PHYSIOLOGIC INDICES OF CARDIOVASCULAR DISEASE (CVD) RISK AND ON RELATED CLINICAL ENDPOINTS. METHODS: WE PERFORMED A LITERATURE SEARCH USING 4 COMPUTERIZED ENGLISH AND INDIAN SCIENTIFIC DATABASES. THE SEARCH WAS RESTRICTED TO ORIGINAL STUDIES (1970 TO 2004) EVALUATING THE EFFECTS OF YOGA ON CVD OR INDICES OF CVD RISK ASSOCIATED WITH THE INSULIN RESISTANCE SYNDROME (IRS). RANDOMIZED CONTROLLED TRIALS (RCTS), NONRANDOMIZED CONTROLLED TRIALS, UNCONTROLLED (PRE AND POST) CLINICAL TRIALS, AND CROSS-SECTIONAL (OBSERVATIONAL) STUDIES WERE INCLUDED IF THEY MET SPECIFIC CRITERIA. DATA WERE EXTRACTED REGARDING STUDY DESIGN, SETTING, POPULATION SIZE AND CHARACTERISTICS, INTERVENTION TYPE AND DURATION, COMPARISON GROUP OR CONDITION, OUTCOME ASSESSMENT, DATA ANALYSIS AND PRESENTATION, FOLLOW-UP, AND KEY RESULTS, AND THE QUALITY OF EACH STUDY WAS EVALUATED ACCORDING TO SPECIFIC PREDETERMINED CRITERIA. RESULTS: WE IDENTIFIED 70 ELIGIBLE STUDIES, INCLUDING 1 OBSERVATIONAL STUDY, 26 UNCONTROLLED CLINICAL TRIALS, 21 NONRANDOMIZED CONTROLLED CLINICAL TRIALS, AND 22 RCTS. TOGETHER, THE REPORTED RESULTS OF THESE STUDIES INDICATE BENEFICIAL CHANGES OVERALL IN SEVERAL IRS-RELATED INDICES OF CVD RISK, INCLUDING GLUCOSE TOLERANCE AND INSULIN SENSITIVITY, LIPID PROFILES, ANTHROPOMETRIC CHARACTERISTICS, BLOOD PRESSURE, OXIDATIVE STRESS, COAGULATION PROFILES, SYMPATHETIC ACTIVATION, AND CARDIOVAGAL FUNCTION, AS WELL AS IMPROVEMENT IN SEVERAL CLINICAL ENDPOINTS. CONCLUSIONS: COLLECTIVELY, THESE STUDIES SUGGEST THAT YOGA MAY REDUCE MANY IRS-RELATED RISK FACTORS FOR CVD, MAY IMPROVE CLINICAL OUTCOMES, AND MAY AID IN THE MANAGEMENT OF CVD AND OTHER IRS-RELATED CONDITIONS. HOWEVER, THE METHODOLOGIC AND OTHER LIMITATIONS CHARACTERIZING MOST OF THESE STUDIES PRECLUDE DRAWING FIRM CONCLUSIONS. ADDITIONAL HIGH QUALITY RCTS ARE NEEDED TO CONFIRM AND FURTHER ELUCIDATE THE EFFECTS OF STANDARDIZED YOGA PROGRAMS ON SPECIFIC INDICES OF CVD RISK AND RELATED CLINICAL ENDPOINTS. 2005 5 1134 22 EFFICACY OF YOGA IN PREGNANT WOMEN WITH ABNORMAL DOPPLER STUDY OF UMBILICAL AND UTERINE ARTERIES. TO STUDY THE EFFICACY OF YOGA ON THE OUTCOME OF COMPLICATED PREGNANCY, 121 WOMEN ATTENDING ANTENATAL CLINIC AT GUNASHEELA SURGICAL AND MATERNITY HOSPITAL (GSMH) IN BANGALORE, INDIA, WERE ENROLLED BETWEEN 18-20 WEEKS OF PREGNANCY IN A PROSPECTIVE, MATCHED, OBSERVATIONAL STUDY. SIXTY-EIGHT WOMEN WERE IN THE YOGA GROUP AND 53 WOMEN IN THE CONTROL GROUP. WOMEN WERE MATCHED FOR AGE, GRAVIDA AND DOPPLER VELOCIMETRY SCORES OF UMBILICAL AND UTERINE ARTERIES. YOGA PRACTICES INCLUDING PHYSICAL POSTURES, BREATHING AND MEDITATION WERE PRACTISED BY THE YOGA GROUP, ONE HOUR DAILY, FROM THE DATE OF ENTRY INTO THE STUDY UNTIL DELIVERY. THE CONTROL GROUP WALKED HALF AN HOUR TWICE A DAY DURING THE STUDY PERIOD. COMPLIANCE IN BOTH THE GROUPS WAS ENSURED. IN BABIES THE BIRTH-WEIGHT IS SIGNIFICANTLY HIGHER (P < 0.018) IN THE YOGA GROUP (2.78 +/- 0.52 KG), COMPARED TO THE CONTROL GROUP (2.55 +/- 0.52 KG). OCCURRENCE OF COMPLICATIONS OF PREGNANCY (PREGNANCY-INDUCED HYPERTENSION, INTRAUTERINE GROWTH RETARDATION, PRE-TERM DELIVERY) SHOWS LOWER TRENDS IN YOGA GROUP. 2005 6 2171 23 THE EFFECTS OF YOGA ON CARDIOVASCULAR RISK FACTORS AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS: SYSTEMATIC REVIEW AND META-ANALYSIS. TYPE 2 DIABETES MELLITUS (T2DM) IS A FASTEST EVOLVING METABOLIC DISORDER AND INDIA HOUSES SECOND HIGHEST NUMBER OF PATIENTS WITH DIABETES AFTER CHINA. CARDIOVASCULAR DISEASES ARE THE MAJOR CAUSE OF MORTALITY AMONG PATIENTS WITH T2DM. YOGA IS AN ANCIENT INDIAN PRACTICE THAT PROVES TO BE EFFECTIVE FOR PATIENTS WITH DIABETES. THE PRESENT SYSTEMATIC REVIEW AND META-ANALYSIS HAS BEEN CONDUCTED TO SEE THE BENEFITS OF YOGA ON BLOOD PRESSURE, LIPID PROFILE, AND ANTHROPOMETRIC MEASURES AMONG PATIENTS WITH T2DM. THE ARTICLES WERE EXTRACTED FROM THREE DATABASES - PUBMED, THE COCHRANE LIBRARY, AND GOOGLE SCHOLAR. ONLY ENGLISH LANGUAGE ARTICLES, WITH PEDRO SCORE>/=6, WERE INCLUDED IN THE CURRENT STUDY. THE DUPLICATES WERE REMOVED USING MENDELEY. FOURTEEN RANDOMIZED CONTROLLED TRIALS (RCTS) AND THREE 3 NON-RCTS WERE INCLUDED IN THE ANALYSIS. THE META-ANALYSIS WAS DONE USING REVIEW MANAGER 5.3. THE RESULTS REVEAL THAT YOGA IS EFFECT IN IMPROVING BLOOD PRESSURE (P<0.01), LIPID PROFILE (P<0.01) EXCEPT HDL (P=0.06), AND ANTHROPOMETRIC MEASURES (P<0.01) EXCEPT WAIST-HIP RATIO (P=0.79). HETEROGENEITY WAS ALSO HIGH FOR MOST OF THE VARIABLES. IT MAY BE CONCLUDED FROM THE RESULTS THAT THE YOGA IS EFFECTIVE IN IMPROVING OF BLOOD PRESSURE, LIPID PROFILE, AND ANTHROPOMETRIC MEASURES. HOWEVER, HIGH HETEROGENEITY SOUGHT THE NEED OF MORE HIGH QUALITY RCTS TO AFFIRM THESE FINDINGS. 2022 7 2523 17 YOGA DURING PREGNANCY: A REVIEW. THE PURPOSE OF THIS REVIEW ARTICLE IS TO EVALUATE THE PERIPARTUM OUTCOMES OF YOGA DURING PREGNANCY, INCLUDING THE POSTPARTUM PERIOD AND LACTATION. THE PUBMED DATABASE WAS ANALYZED FROM JANUARY 1970 TO JANUARY 2011. WE IDENTIFIED FIVE PROSPECTIVE OBSERVATIONAL STUDIES (N = 575) AND THREE RANDOMIZED CLINICAL TRIALS (RCTS; N = 298), WHICH WERE ANALYZED SEPARATELY. THE NONRANDOMIZED TRIALS INDICATED A SIGNIFICANT REDUCTION IN RATES OF PRETERM LABOR (P < 0.0006), INTRAUTERINE GROWTH RETARDATION (P <0.003), LOW BIRTH WEIGHT (P < 0.01), PREGNANCY DISCOMFORTS (P = 0.01), AND PERCEIVED SLEEP DISTURBANCES (P = 0.03) IN THOSE WHO PRACTICED YOGA DURING PREGNANCY. RESULTS OF THE RCTS INDICATED THAT DOING YOGA DURING PREGNANCY CAN SIGNIFICANTLY LOWER PAIN AND DISCOMFORT (P < 0.05) AND PERCEIVED STRESS (P = 0.001) AND IMPROVE QUALITY OF LIFE IN PHYSICAL DOMAINS (P = 0.001). ALL THREE RCTS WERE POORLY COMPLIANT WITH THE CONSOLIDATED STANDARD OF REPORTING TRIALS STATEMENT. WHILE AWAITING AN APPROPRIATELY DESIGNED RCT TO DETERMINE THE BENEFITS OF YOGA DURING PREGNANCY, IT REMAINS A VIABLE EXERCISE OPTION. 2012 8 2539 24 YOGA FOR ADULTS WITH TYPE 2 DIABETES: A SYSTEMATIC REVIEW OF CONTROLLED TRIALS. A GROWING BODY OF EVIDENCE SUGGESTS YOGIC PRACTICES MAY BENEFIT ADULTS WITH TYPE 2 DIABETES (DM2). IN THIS SYSTEMATIC REVIEW, WE EVALUATE AVAILABLE EVIDENCE FROM PROSPECTIVE CONTROLLED TRIALS REGARDING THE EFFECTS OF YOGA-BASED PROGRAMS ON SPECIFIC HEALTH OUTCOMES PERTINENT TO DM2 MANAGEMENT. TO IDENTIFY QUALIFYING STUDIES, WE SEARCHED NINE DATABASES AND SCANNED BIBLIOGRAPHIES OF RELEVANT REVIEW PAPERS AND ALL IDENTIFIED ARTICLES. CONTROLLED TRIALS THAT DID NOT TARGET ADULTS WITH DIABETES, INCLUDED ONLY ADULTS WITH TYPE 1 DIABETES, WERE UNDER TWO-WEEK DURATION, OR DID NOT INCLUDE QUANTITATIVE OUTCOME DATA WERE EXCLUDED. STUDY QUALITY WAS EVALUATED USING THE PEDRO SCALE. THIRTY-THREE PAPERS REPORTING FINDINGS FROM 25 CONTROLLED TRIALS (13 NONRANDOMIZED, 12 RANDOMIZED) MET OUR INCLUSION CRITERIA (N = 2170 PARTICIPANTS). COLLECTIVELY, FINDINGS SUGGEST THAT YOGIC PRACTICES MAY PROMOTE SIGNIFICANT IMPROVEMENTS IN SEVERAL INDICES OF IMPORTANCE IN DM2 MANAGEMENT, INCLUDING GLYCEMIC CONTROL, LIPID LEVELS, AND BODY COMPOSITION. MORE LIMITED DATA SUGGEST THAT YOGA MAY ALSO LOWER OXIDATIVE STRESS AND BLOOD PRESSURE; ENHANCE PULMONARY AND AUTONOMIC FUNCTION, MOOD, SLEEP, AND QUALITY OF LIFE; AND REDUCE MEDICATION USE IN ADULTS WITH DM2. HOWEVER, GIVEN THE METHODOLOGICAL LIMITATIONS OF EXISTING STUDIES, ADDITIONAL HIGH-QUALITY INVESTIGATIONS ARE REQUIRED TO CONFIRM AND FURTHER ELUCIDATE THE POTENTIAL BENEFITS OF YOGA PROGRAMS IN POPULATIONS WITH DM2. 2016 9 1374 29 IMPACT OF AN INTEGRATED YOGA THERAPY PROTOCOL ON INSULIN RESISTANCE AND GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. OBJECTIVE: DIABETES MELLITUS (DM), CHARACTERIZED BY CHRONIC HYPERGLYCEMIA, IS ATTRIBUTED TO RELATIVE INSULIN DEFICIENCY OR RESISTANCE, OR BOTH. STUDIES HAVE SHOWN THAT YOGA CAN MODULATE PARAMETERS OF INSULIN RESISTANCE. THE PRESENT STUDY EXPLORED THE POSSIBLE BENEFICIAL EFFECTS OF INTEGRATED YOGA THERAPY WITH REFERENCE TO GLYCEMIC CONTROL AND INSULIN RESISTANCE (IR) IN INDIVIDUALS WITH DIABETES MAINTAINED ON STANDARD ORAL MEDICAL CARE WITH YOGA THERAPY, COMPARED TO THOSE ON STANDARD ORAL MEDICAL CARE ALONE. METHODS: IN THIS STUDY, THE SUBJECTS ON YOGA INTERVENTION COMPRISED 35 TYPE 2 DIABETICS, AND AN EQUAL NUMBER OF VOLUNTEERS CONSTITUTED THE CONTROL GROUP. SUBJECTS RANGED IN AGE FROM 30 TO 70 YEARS, WITH HEMOGLOBIN A1C (HBA1C) TEST MORE THAN 7%, AND WERE MAINTAINED ON DIABETIC DIET AND ORAL HYPOGLYCEMIC AGENTS. BLOOD SAMPLES WERE DRAWN PRIOR TO AND AFTER 120 DAYS OF INTEGRATED YOGA THERAPY INTERVENTION. FASTING BLOOD GLUCOSE (FBG), POST-PRANDIAL BLOOD GLUCOSE (PPBG), HBA1C, INSULIN, AND LIPID PROFILE WERE ASSESSED IN BOTH THE INTERVENTION AND CONTROL GROUPS. RESULTS: THE INTERVENTION GROUP REVEALED SIGNIFICANT IMPROVEMENTS IN BODY MASS INDEX (BMI) (0.7 KG/M(2) MEDIAN DECREASE; P=0.001), FBG (20 MG/DL MEDIAN DECREASE; P<0.001), PPBG (33 MG/DL MEDIAN DECREASE; P<0.001), HBA1C (0.4% MEDIAN DECREASE; P<0.001), HOMEOSTATIC MODEL ASSESSMENT FOR INSULIN RESISTANCE (HOMA-IR) (1.2 MEDIAN DECREASE; P<0.001), CHOLESTEROL (13 MG/DL MEDIAN DECREASE, P=0.006), TRIACYLGLYCEROL (22 MG/DL MEDIAN DECREASE; P=0.027), LOW-DENSITY LIPOPROTEIN (6 MG/DL MEDIAN DECREASE; P=0.004), AND VERY-LOW-DENSITY LIPOPROTEIN LEVELS (4 MG/DL MEDIAN DECREASE; P=0.032). INCREASES IN HIGH-DENSITY LIPOPROTEIN AFTER 120 DAYS WERE NOT SIGNIFICANT (6 MG/DL MEDIAN INCREASE; P=0.15). HOWEVER, WHEN COMPARED TO CHANGES OBSERVED IN PATIENTS IN THE CONTROL GROUP, ALL THESE IMPROVEMENTS PROVED TO BE SIGNIFICANT. CONCLUSION: ADMINISTRATION OF INTEGRATED YOGA THERAPY TO INDIVIDUALS WITH DIABETES LEADS TO A SIGNIFICANT IMPROVEMENT IN GLYCEMIC CONTROL, INSULIN RESISTANCE, AND KEY BIOCHEMICAL PARAMETERS. 2022 10 692 24 EFFECT OF COMMUNITY-BASED YOGA INTERVENTION ON OXIDATIVE STRESS AND GLYCEMIC PARAMETERS IN PREDIABETES: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVES: TO STUDY THE EFFECTIVENESS OF YOGA INTERVENTION ON OXIDATIVE STRESS, GLYCEMIC STATUS, BLOOD PRESSURE AND ANTHROPOMETRY IN PREDIABETES. DESIGN: RANDOMIZED-CONTROLLED TRIAL. PARTICIPANTS: TWENTY NINE PREDIABETES SUBJECTS AGED 30-75 YEARS. SETTING: YOGA WAS CONDUCTED AT 4 DIFFERENT COMMUNITY DIABETES CLINICS IN MANGALORE, INDIA. INTERVENTIONS: PARTICIPANTS WERE RANDOMIZED TO EITHER 3-MONTH YOGA OR WAIT-LIST CONTROL GROUPS. MAIN OUTCOME MEASURES: MALONDIALDEHYDE, GLUTATHIONE, VITAMIN C, VITAMIN E, SUPEROXIDE DISMUTASE, PLASMA GLUCOSE, GLYCATED HAEMOGLOBIN, BMI, WAIST CIRCUMFERENCE, WAIST-TO-HIP RATIO AND BLOOD PRESSURE. RESULTS: YOGA INTERVENTION RESULTED IN A SIGNIFICANT DECLINE IN MALONDIALDEHYDE (P<0.001), RELATIVE TO THE CONTROL GROUP. IN COMPARISON WITH THE CONTROL, THERE WAS A SIGNIFICANT IMPROVEMENT IN BMI, WAIST CIRCUMFERENCE, SYSTOLIC BLOOD PRESSURE AND FASTING GLUCOSE LEVELS AT FOLLOW-UP. NO SIGNIFICANT IMPROVEMENT IN GLYCATED HAEMOGLOBIN, WAIST-TO-HIP RATIO OR ANY OF THE ANTIOXIDANTS WAS OBSERVED. CONCLUSIONS: YOGA INTERVENTION MAY BE HELPFUL IN CONTROL OF OXIDATIVE STRESS IN PREDIABETES SUBJECTS. YOGA CAN ALSO BE BENEFICIAL IN REDUCTION IN BMI, WAIST CIRCUMFERENCE, SYSTOLIC BLOOD PRESSURE AND FASTING GLUCOSE. EFFECT OF YOGA ON ANTIOXIDANT PARAMETERS WAS NOT EVIDENT IN THIS STUDY. THE FINDINGS OF THIS STUDY NEED TO BE CONFIRMED IN LARGER TRIALS INVOLVING ACTIVE CONTROL GROUPS. 2013 11 679 19 EFFECT OF A YOGA PROGRAM ON GLUCOSE METABOLISM AND BLOOD LIPID LEVELS IN ADOLESCENT GIRLS WITH POLYCYSTIC OVARY SYNDROME. OBJECTIVE: TO ASSESS THE EFFICACY OF YOGA THERAPY ON GLUCOSE METABOLISM AND BLOOD LIPID VALUES IN ADOLESCENT GIRLS WITH POLYCYSTIC OVARY SYNDROME (PCOS). METHODS: A PROSPECTIVE, RANDOMIZED, INTERVENTIONAL CONTROLLED TRIAL RECRUITED 90 ADOLESCENTS AGED BETWEEN 15 AND 18 YEARS WHO MET THE ROTTERDAM CRITERIA FOR PCOS. A YOGA GROUP PRACTICED SURYANAMASKARA, ASANAS, PRANAYAMA, AND MEDITATION 1 HOUR PER DAY EACH DAY FOR 12 WEEKS WHILE ANOTHER GROUP PRACTICED CONVENTIONAL PHYSICAL EXERCISES. THE MANN-WHITNEY U TEST WAS USED TO COMPARE SCORE CHANGES BETWEEN THE 2 GROUPS. RESULTS: THE CHANGES IN FASTING INSULIN, FASTING BLOOD GLUCOSE, AND HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE WERE SIGNIFICANTLY DIFFERENT IN THE 2 GROUPS (P<0.05). EXCEPT FOR HIGH-DENSITY LIPOPROTEIN CHOLESTEROL, THE CHANGES IN BLOOD LIPID VALUES WERE ALSO SIGNIFICANTLY DIFFERENT (P<0.05). THE CHANGES IN BODY MASS INDEX, WAIST CIRCUMFERENCE, HIP CIRCUMFERENCE, AND WAIST-TO-HIP RATIO, HOWEVER, WERE NOT SIGNIFICANTLY DIFFERENT (P>0.05). CONCLUSION: YOGA WAS FOUND TO BE MORE EFFECTIVE THAN CONVENTIONAL PHYSICAL EXERCISES IN IMPROVING GLUCOSE, LIPID, AND INSULIN VALUES, INCLUDING INSULIN RESISTANCE VALUES, IN ADOLESCENT GIRLS WITH PCOS INDEPENDENT OF ANTHROPOMETRIC CHANGES. CENTRAL TRIAL REGISTRY OF INDIA NO.: REFCTRI-2008 000291. 2012 12 477 21 CLINICAL APPLICATIONS OF YOGA FOR THE PEDIATRIC POPULATION: A SYSTEMATIC REVIEW. OBJECTIVE: THE AIM OF THIS STUDY WAS TO EVALUATE THE EVIDENCE FOR CLINICAL APPLICATIONS OF YOGA AMONG THE PEDIATRIC POPULATION. METHODS: WE CONDUCTED AN ELECTRONIC LITERATURE SEARCH INCLUDING CINAHL, COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS (CENTRAL), EMBASE, MEDLINE, PSYCINFO, AND MANUAL SEARCH OF RETRIEVED ARTICLES FROM INCEPTION OF EACH DATABASE UNTIL DECEMBER 2008. RANDOMIZED CONTROLLED TRIALS (RCTS) AND NONRANDOMIZED CONTROLLED TRIALS (NRCTS) WERE SELECTED THAT INCLUDED YOGA OR YOGA-BASED INTERVENTIONS FOR INDIVIDUALS AGED 0 TO 21 YEARS. DATA WERE EXTRACTED AND ARTICLES CRITICALLY REVIEWED USING A MODIFIED JADAD SCORE AND DESCRIPTIVE METHODOLOGICAL CRITERIA, WITH SUMMARIZATION IN TABLES. RESULTS: THIRTY-FOUR CONTROLLED STUDIES PUBLISHED FROM 1979 TO 2008 WERE IDENTIFIED, WITH 19 RCTS AND 15 NRCTS. MANY STUDIES WERE OF LOW METHODOLOGICAL QUALITY. CLINICAL AREAS FOR WHICH YOGA HAS BEEN STUDIED INCLUDE PHYSICAL FITNESS, CARDIORESPIRATORY EFFECTS, MOTOR SKILLS/STRENGTH, MENTAL HEALTH AND PSYCHOLOGICAL DISORDERS, BEHAVIOR AND DEVELOPMENT, IRRITABLE BOWEL SYNDROME, AND BIRTH OUTCOMES FOLLOWING PRENATAL YOGA. NO ADVERSE EVENTS WERE REPORTED IN TRIALS REVIEWED. ALTHOUGH A LARGE MAJORITY OF STUDIES WERE POSITIVE, METHODOLOGICAL LIMITATIONS SUCH AS RANDOMIZATION METHODS, WITHDRAWAL/DROPOUTS, AND DETAILS OF YOGA INTERVENTION PRECLUDE CONCLUSIVE EVIDENCE. CONCLUSIONS: THERE ARE LIMITED DATA ON THE CLINICAL APPLICATIONS OF YOGA AMONG THE PEDIATRIC POPULATION. MOST PUBLISHED CONTROLLED TRIALS WERE SUGGESTIVE OF BENEFIT, BUT RESULTS ARE PRELIMINARY BASED ON LOW QUANTITY AND QUALITY OF TRIALS. FURTHER RESEARCH OF YOGA FOR CHILDREN BY USING A HIGHER STANDARD OF METHODOLOGY AND REPORTING IS WARRANTED. 2009 13 236 21 A SYSTEMATIC REVIEW: THE EFFECTS OF YOGA ON PREGNANCY. OBJECTIVE: A SYSTEMATIC REVIEW WAS CONDUCTED TO UPDATE AND PROVIDE A COMPREHENSIVE OVERVIEW ON THE PSYCHOLOGICAL EFFECTS OF ANTENATAL YOGA ON PREGNANCY COMPARED TO STANDARD PRENATAL CARE. STUDY DESIGN: FOUR DATABASES WERE SEARCHED USING KEYWORDS "YOGA", "PREGNANCY", "PERINATAL CARE", "PRENATAL CARE", "POSTNATAL CARE", "POSTPARTUM PERIOD", "PERIPARTUM PERIOD", "PATIENT OUTCOME ASSESSMENT", "OUTCOME ASSESSMENT", "PREGNANCY OUTCOME", "TREATMENT OUTCOME". TRIALS WERE CONSIDERED IF THEY WERE RANDOMIZED CONTROLLED TRIALS (RCTS) PUBLISHED FROM 2011 TO 2018 AND EVALUATED AN ANTENATAL YOGA INTERVENTION. ALL STUDIES WERE ASSESSED FOR RISK OF BIAS USING THE COCHRANE CRITERIA. TRIAL CHARACTERISTICS AND OUTCOMES WERE EXTRACTED AND SYNTHESIZED DESCRIPTIVELY WHERE POSSIBLE. DUE TO HETEROGENEITY, META-ANALYSIS WAS NOT POSSIBLE. RESULTS: OF THE 175 NON-DUPLICATED STUDIES, 16 MET CRITERIA FOR FULL-TEXT REVIEW. FIVE RCTS MET THE INCLUSION CRITERIA AND WERE INCLUDED IN THE SYSTEMATIC REVIEW. THE FINDINGS OF THE RCTS SUGGEST ANTENATAL YOGA MAY BE SAFE AND MAY EFFECTIVELY DECREASE STRESS LEVELS, ANXIETY SCORES, DEPRESSION SCORES, AND PAIN RESPONSE AS WELL AS INCREASING MATERNAL IMMUNITY AND EMOTIONAL-WELLBEING. CONCLUSION: YOGA APPEARS TO BE SAFE AND MAY IMPROVE PSYCHOLOGICAL AND PREGNANCY OUTCOMES. HOWEVER, DUE TO THE LIMITED NUMBER OF STUDIES, MORE HIGH-QUALITY, LARGE RCTS ARE NEEDED TO DRAW CONCLUSIONS ABOUT IMPROVEMENT IN OTHER PREGNANCY OUTCOMES. 2020 14 1104 18 EFFECTS OF YOGA VERSUS SHAM YOGA ON OXIDATIVE STRESS, GLYCEMIC STATUS, AND ANTHROPOMETRY IN TYPE 2 DIABETES MELLITUS: A SINGLE-BLINDED RANDOMIZED PILOT STUDY. STUDIES HAVE SHOWN A BENEFICIAL ROLE OF YOGA IN TRE A T I N G TYPE 2 DIABETES MELLITUS. THE PRESENT STUDY PROCEEDS IN THE FIELD BY PROVIDING AN ACTIVE CONTROL. WE AIMED TO EVALUATE THE EFFECT OF 3 MONTHS OF YOGA ON OXIDATIVE STRESS, GLYCEMIC STATUS, AND ANTHROPOMETRY IN TYPE 2 DIABETES MELLITUS. FORTY PARTICIPANTS WERE RANDOMIZED TO RECEIVE EITHER YOGA (N = 20) OR SHAM YOGA (N = 20) AS A CONTROL. YOGA INCLUDED POSTURES AND BREATHING EXERCISES, AND NONAEROBIC STRETCHING EXERCISE COMPRISED THE CONTROL. SIGNIFICANT WITHIN-GROUP DIFFERENCES IN MALONDIALDEHYDE, VITAMIN C, SUPEROXIDE DISMUTASE, FASTING BLOOD GLUCOSE, GLYCOSYLATED HEMOGLOBIN, BODY MASS INDEX, WAIST CIRCUMFERENCE, AND BLOOD PRESSURE WERE EVIDENT IN BOTH GROUPS. YOGA PARTICIPANTS HAD SIGNIFICANTLY GREATER IMPROVEMENT IN REDUCED GLUTATHIONE COMPARED TO CONTROLS. NO SIGNIFICANT DIFFERENCES BETWEEN GROUPS WERE OBSERVED IN ANY OTHER OUTCOME VARIABLES. YOGA AND SHAM YOGA HAD IDENTICAL EFFECTS ON OXIDATIVE STRESS, GLYCEMIC STATUS, AND ANTHROPOMETRY IN TYPE 2 DIABETES MELLITUS. LEVELS OF REDUCED GLUTATHIONE IMPROVED ONLY IN THE YOGA GROUP. THIS RESEARCH NEEDS TO BE CONFIRMED BY LARGER AND SUFFICIENTLY POWERED STUDIES. 2020 15 2169 23 THE EFFECTS OF YOGA IN PREVENTION OF PREGNANCY COMPLICATIONS IN HIGH-RISK PREGNANCIES: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVE: WHILE PREVIOUS STUDIES HAVE SHOWN THE POTENTIAL EFFECTS OF YOGA IN NORMAL PREGNANCIES, THIS RANDOMIZED CONTROLLED TRIAL INVESTIGATED THE EFFECTS OF YOGA IN PREVENTION OF PREGNANCY COMPLICATIONS IN HIGH-RISK PREGNANCIES FOR THE FIRST TIME. METHODS: 68 HIGH-RISK PREGNANT WOMEN WERE RECRUITED FROM TWO MATERNITY HOSPITALS IN BENGALURU, INDIA AND WERE RANDOMIZED INTO YOGA AND CONTROL GROUPS. THE YOGA GROUP (N=30) RECEIVED STANDARD CARE PLUS ONE-HOUR YOGA SESSIONS, THREE TIMES A WEEK, FROM THE 12TH TO THE 28TH WEEK OF GESTATION. THE CONTROL GROUP (N=38) RECEIVED STANDARD CARE PLUS CONVENTIONAL ANTENATAL EXERCISES (WALKING) DURING THE SAME PERIOD. RESULTS: SIGNIFICANTLY FEWER PREGNANCY INDUCED HYPERTENSION (PIH), PREECLAMPSIA, GESTATIONAL DIABETES (GDM) AND INTRAUTERINE GROWTH RESTRICTION (IUGR) CASES WERE OBSERVED IN THE YOGA GROUP (P=0.018, 0.042, 0.049, 0.05 RESPECTIVELY). SIGNIFICANTLY FEWER SMALL FOR GESTATIONAL AGE (SGA) BABIES AND NEWBORNS WITH LOW APGAR SCORES (P=0.006) WERE BORN IN THE YOGA GROUP (P=0.033). CONCLUSION: THIS FIRST RANDOMIZED STUDY OF YOGA IN HIGH-RISK PREGNANCY HAS SHOWN THAT YOGA CAN POTENTIALLY BE AN EFFECTIVE THERAPY IN REDUCING HYPERTENSIVE RELATED COMPLICATIONS OF PREGNANCY AND IMPROVING FETAL OUTCOMES. ADDITIONAL DATA IS NEEDED TO CONFIRM THESE RESULTS AND BETTER EXPLAIN THE MECHANISM OF ACTION OF YOGA IN THIS IMPORTANT AREA. 2012 16 1824 26 PSYCHO-NEURO-ENDOCRINE-IMMUNE MECHANISMS OF ACTION OF YOGA IN TYPE II DIABETES. YOGA HAS BEEN FOUND TO BENEFIT ALL THE COMPONENTS OF HEALTH VIZ. PHYSICAL, MENTAL, SOCIAL AND SPIRITUAL WELL BEING BY INCORPORATING A WIDE VARIETY OF PRACTICES. PATHOPHYSIOLOGY OF TYPE II DM AND CO-MORBIDITIES IN TYPE II DM HAS BEEN CORRELATED WITH STRESS MECHANISMS. STRESS SUPPRESSES BODY'S IMMUNE SYSTEM AND NEURO-HUMORAL ACTIONS THEREBY AFF ECTING NORMAL PSYCHOLOGICAL STATE. IT WOULD NOT BE WRONG TO STATE THAT CORRELATION OF DIABETES WITH STRESS, ANXIETY AND OTHER PSYCHOLOGICAL FACTORS ARE BIDIRECTIONAL AND LEAD TO DIFFICULTY IN UNDERSTANDING THE INTERRELATED MECHANISMS. TYPE II DM CANNOT BE UNDERSTOOD IN ISOLATION WITH PSYCHOLOGICAL FACTORS SUCH AS STRESS, ANXIETY AND DEPRESSION, NEURO-ENDOCRINE AND IMMUNOLOGICAL FACTORS. THERE IS NO REVIEW WHICH TRIES TO UNDERSTAND THESE MECHANISMS EXCLUSIVELY. THE PRESENT LITERATURE REVIEW AIMS TO UNDERSTAND INTERRELATED PSYCHO-NEURO-ENDOCRINE AND IMMUNOLOGICAL MECHANISMS OF ACTION OF YOGA IN TYPE II DIABETES MELLITUS. PUBLISHED LITERATURE CONCERNING MECHANISMS OF ACTION OF YOGA IN TYPE II DM EMPHASIZING PSYCHO-NEURO-ENDOCRINE OR IMMUNOLOGICAL RELATIONS WAS RETRIEVED FROM PUBMED USING KEY WORDS YOGA, TYPE II DIABETES MELLITUS, PSYCHOLOGICAL, NEURAL, ENDOCRINE, IMMUNE AND MECHANISM OF ACTION. THOSE STUDIES WHICH EXPLAINED THE PSYCHO-NEUROENDOCRINE AND IMMUNE MECHANISMS OF ACTION OF YOGA WERE INCLUDED AND REST WERE EXCLUDED. ALTHOUGH PRIMARY AIM OF THIS STUDY IS TO EXPLAIN THESE MECHANISMS IN TYPE II DM, SOME STUDIES IN NON-DIABETIC POPULATION WHICH HAD A SIMILAR PATHWAY OF STRESS MECHANISM WAS INCLUDED BECAUSE MANY INSIGHTFUL STUDIES WERE AVAILABLE IN THAT AREA. SEARCH WAS CONDUCTED USING TERMS YOGA OR YOGIC AND DIABETES OR DIABETIC IN TITLE OR ABSTRACT FOR ENGLISH ARTICLES. OF THE 89 ARTICLES, WE EXCLUDED NON-ENGLISH ARTICLES (22), EDITORIALS (20) AND LETTERS TO EDITOR (10). 37 STUDIES WERE CONSIDERED FOR THIS REVIEW. THE POSTULATED MECHANISM OF ACTION OF YOGA IS THROUGH PARASYMPATHETIC ACTIVATION AND THE ASSOCIATED ANTI STRESS MECHANISM. IT REDUCES PERCEIVED STRESS AND HPA AXIS ACTIVATION THEREBY IMPROVING OVERALL METABOLIC AND PSYCHOLOGICAL PROFILES, INCREASING INSULIN SENSITIVITY, AND IMPROVING GLUCOSE TOLERANCE AND LIPID METABOLISM. YOGA HAS POSITIVE EFFECTS ON IMMUNE SYSTEM OF DIABETICS.- OVERALL, TYPE II DM IS INFLUENCED BY PSYCHO-NEURO-ENDOCRINE AND IMMUNE MECHANISMS WHERE YOGA HAS IMPORTANT POSITIVE ROLE IN COMBATING STRESSORS AND IMPROVING THESE SYSTEMS TO REGAIN HEALTH. 2015 17 1936 18 ROLE OF YOGA IN THE PREVENTION AND MANAGEMENT OF VARIOUS CARDIOVASCULAR DISEASES AND THEIR RISK FACTORS: A COMPREHENSIVE SCIENTIFIC EVIDENCE-BASED REVIEW. CARDIOVASCULAR DISEASES (CVDS) ARE A GROUP OF DISORDERS OF THE HEART AND BLOOD VESSELS. CVDS ARE THE LEADING CAUSE OF DEATHS WORLDWIDE. THOUGH YOGA IS GAINING POPULARITY AS A THERAPY, ESPECIALLY IN CVD PATIENTS, THERE IS A LACK OF A COMPREHENSIVE REVIEW REPORTING ITS ROLE IN THE MANAGEMENT OF VARIOUS CVDS AND THEIR RISK FACTORS. THUS, WE PERFORMED A COMPREHENSIVE LITERATURE SEARCH IN THE PUBMED/MEDLINE ELECTRONIC DATABASE. AN AGGREGATE OF 603 ARTICLES PUBLISHED FROM INCEPTION WERE SCREENED AND 85 ARTICLES THAT ARE APPLICABLE WERE REPORTED. THIS REVIEW SUGGESTS THAT YOGA MAY PLAY A ROLE AS AN ADJUVANT IN THE MANAGEMENT OF VARIOUS CVDS AND THEIR RISK FACTORS. HOWEVER, MANY STUDIES HAD A SMALL SAMPLE SIZE, DIFFERENT TYPES AND DURATIONS OF THE YOGA INTERVENTIONS, AND DID NOT PROVIDE THE DETAILS OF MECHANISMS BEHIND THE IMPROVEMENTS. THUS, FURTHER STUDIES ARE WARRANTED TO EXPLORE THE MECHANISMS OF THE IMPACTS OF YOGA. 2020 18 2295 28 THERAPEUTIC POTENTIAL OF YOGA PRACTICES IN MODIFYING CARDIOVASCULAR RISK PROFILE IN MIDDLE AGED MEN AND WOMEN. AIMS OF STUDY: TO STUDY EFFECT OF YOGA ON THE PHYSIOLOGICAL, PSYCHOLOGICAL WELL BEING, PSYCHOMOTOR PARAMETER AND MODIFYING CARDIOVASCULAR RISK FACTORS IN MILD TO MODERATE HYPERTENSIVE PATIENTS. METHODS: TWENTY PATIENTS (16 MALES, 4 FEMALES) IN THE AGE GROUP OF 35 TO 55 YEARS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION UNDERWENT YOGIC PRACTICES DAILY FOR ONE HOUR FOR THREE MONTHS. BIOCHEMICAL, PHYSIOLOGICAL AND PSYCHOLOGICAL PARAMETERS WERE STUDIED PRIOR AND FOLLOWING PERIOD OF THREE MONTHS OF YOGA PRACTICES, BIOCHEMICAL PARAMETERS INCLUDED, BLOOD GLUCOSE, LIPID PROFILE, CATECHOLMINES, MDA, VIT. C CHOLINESTERASE AND URINARY VMA. PSYCHOLOGICAL EVALUATION WAS DONE BY USING PERSONAL ORIENTATION INVENTORY AND SUBJECTIVE WELL BEING. RESULTS: RESULTS SHOWED DECREASE IN BLOOD PRESSURE AND DRUG SCORE MODIFYING RISK FACTORS, I.E. BLOOD GLUCOSE, CHOLESTEROL AND TRIGLYCERIDES DECREASED OVERALL IMPROVEMENT IN SUBJECTIVE WELL BEING AND QUALITY OF LIFE. THERE WAS DECREASE IN VMA CATECHOLAMINE, AND DECREASE MDA LEVEL SUGGESTIVE DECREASE SYMPATHETIC ACTIVITY AND OXIDANT STRESS. CONCLUSION: YOGA CAN PLAY AN IMPORTANT ROLE IN RISK MODIFICATION FOR CARDIOVASCULAR DISEASES IN MILD TO MODERATE HYPERTENSION. 2002 19 2585 20 YOGA FOR HYPERTENSION: A SYSTEMATIC REVIEW OF RANDOMIZED CLINICAL TRIALS. OBJECTIVES: TO CRITICALLY EVALUATE THE EFFECTIVENESS OF YOGA AS A TREATMENT OF HYPERTENSION. METHODS: SEVENTEEN DATABASES WERE SEARCHED FROM THEIR INCEPTIONS TO JANUARY 2014. RANDOMIZED CLINICAL TRIALS (RCTS) WERE INCLUDED, IF THEY EVALUATED YOGA AGAINST ANY TYPE OF CONTROL IN PATIENTS WITH ANY FORM OF ARTERIAL HYPERTENSION. RISK OF BIAS WAS ESTIMATED USING THE COCHRANE CRITERIA. THREE INDEPENDENT REVIEWERS PERFORMED THE SELECTION OF STUDIES, DATA EXTRACTION, AND QUALITY ASSESSMENTS. RESULTS: SEVENTEEN TRIALS MET THE INCLUSION CRITERIA. ONLY TWO RCTS WERE OF ACCEPTABLE METHODOLOGICAL QUALITY. ELEVEN RCTS SUGGESTED THAT YOGA LEADS TO A SIGNIFICANTLY GREATER REDUCTION IN SYSTOLIC BLOOD PRESSURE (SBP) COMPARED TO VARIOUS FORMS OF PHARMACOTHERAPY, BREATH AWARENESS OR READING, HEALTH EDUCATION, NO TREATMENT (NT), OR USUAL CARE (UC). EIGHT RCTS SUGGESTED THAT YOGA LEADS TO A SIGNIFICANTLY GREATER REDUCTION IN DIASTOLIC BLOOD PRESSURE (DBP) OR NIGHT-TIME DBP COMPARED TO PHARMACOTHERAPY, NT, OR UC. FIVE RCTS INDICATED THAT YOGA HAD NO EFFECT ON SBP COMPARED TO DIETARY MODIFICATION (DIM), ENHANCED UC, PASSIVE RELAXATION (PR), OR PHYSICAL EXERCISES (PE). EIGHT RCTS INDICATED THAT YOGA HAD NO EFFECT ON DBP COMPARED TO DIM, ENHANCED UC, PHARMACOTHERAPY, NT, PE, PR, OR BREATH AWARENESS OR READING. ONE RCT DID NOT REPORT BETWEEN-GROUP COMPARISONS. CONCLUSION: THE EVIDENCE FOR THE EFFECTIVENESS OF YOGA AS A TREATMENT OF HYPERTENSION IS ENCOURAGING BUT INCONCLUSIVE. FURTHER, MORE RIGOROUS TRIALS SEEM WARRANTED. 2014 20 39 36 A BRIEF BUT COMPREHENSIVE LIFESTYLE EDUCATION PROGRAM BASED ON YOGA REDUCES RISK FACTORS FOR CARDIOVASCULAR DISEASE AND DIABETES MELLITUS. OBJECTIVES: THE OBJECTIVE OF THE STUDY WAS TO STUDY THE SHORT-TERM IMPACT OF A BRIEF LIFESTYLE INTERVENTION BASED ON YOGA ON SOME OF THE BIOCHEMICAL INDICATORS OF RISK FOR CARDIOVASCULAR DISEASE AND DIABETES MELLITUS. DESIGN: THE VARIABLES OF INTEREST WERE MEASURED AT THE BEGINNING (DAY 1) AND END (DAY 10) OF THE INTERVENTION USING A PRE-POST DESIGN. SETTING: THE STUDY IS THE RESULT OF OPERATIONAL RESEARCH CARRIED OUT IN OUR INTEGRAL HEALTH CLINIC (IHC). THE IHC IS AN OUTPATIENT FACILITY WHICH CONDUCTS 8-DAY LIFESTYLE MODIFICATION PROGRAMS BASED ON YOGA FOR PREVENTION AND MANAGEMENT OF CHRONIC DISEASE. A NEW COURSE BEGINS EVERY ALTERNATE WEEK OF THE YEAR. SUBJECTS: THE STUDY IS BASED ON DATA COLLECTED ON 98 SUBJECTS (67 MALE, 31 FEMALE), AGES 20-74 YEARS, WHO ATTENDED ONE OF OUR PROGRAMS. THE SUBJECTS WERE A HETEROGENEOUS GROUP OF PATIENTS WITH HYPERTENSION, CORONARY ARTERY DISEASE, DIABETES MELLITUS, AND A VARIETY OF OTHER ILLNESSES. INTERVENTION: THE INTERVENTION CONSISTED OF ASANAS (POSTURES), PRANAYAMA (BREATHING EXERCISES), RELAXATION TECHNIQUES, GROUP SUPPORT, INDIVIDUALIZED ADVICE, LECTURES AND FILMS ON THE PHILOSOPHY OF YOGA AND THE PLACE OF YOGA IN DAILY LIFE, MEDITATION, STRESS MANAGEMENT, NUTRITION, AND KNOWLEDGE ABOUT THE ILLNESS. OUTCOME MEASURES: THE OUTCOME MEASURES WERE FASTING PLASMA GLUCOSE AND SERUM LIPOPROTEIN PROFILE. THESE VARIABLES WERE DETERMINED IN FASTING BLOOD SAMPLES, TAKEN ON THE FIRST AND LAST DAY OF THE COURSE. RESULTS: FASTING PLASMA GLUCOSE, SERUM TOTAL CHOLESTEROL, LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL, VERY- LDL CHOLESTEROL, THE RATIO OF TOTAL CHOLESTEROL TO HIGH DENSITY LIPOPROTEIN (HDL) CHOLESTEROL, AND TOTAL TRIGLYCERIDES WERE SIGNIFICANTLY LOWER, AND HDL CHOLESTEROL SIGNIFICANTLY HIGHER, ON THE LAST DAY OF THE COURSE COMPARED TO THE FIRST DAY OF THE COURSE. THE CHANGES WERE MORE MARKED IN SUBJECTS WITH HYPERGLYCEMIA OR HYPERCHOLESTEROLEMIA. CONCLUSIONS: THE OBSERVATIONS SUGGEST THAT A SHORT LIFESTYLE MODIFICATION AND STRESS MANAGEMENT EDUCATION PROGRAM LEADS TO FAVORABLE METABOLIC EFFECTS WITHIN A PERIOD OF 9 DAYS. 2005